India's Aarti Drugs rises after Gujarat authority revokes closure of plant

Aarti Drugs

21/03/2024 05:29

** Shares of Aarti Drugs  ADRG.NS  rise 3.9% to 454.7 rupees;
last up ~3.2% 
    ** The Gujarat Pollution Control Board (GPCB) permanently
revoked a closure order issued for co's Sarigam Plant, dated
March 30, 2022
    ** The plant manufactures diabetes drug metformin
hydrochloride; a trial revocation of the closure was issued on
April 30, 2022
    ** Stock on track to snap two consecutive session of losses
    ** Still, stock eyes fourth consecutive week of losses
    ** Stock down nearly 7.6% YTD vs 9.9% rise in Nifty pharma
index  .NIPHARM 

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))